| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |